Semaglutide Side Effects: What to Expect and When to Worry

What You're Actually Signing Up For

If you're starting semaglutide — whether that's Ozempic, Wegovy, or the new oral Wegovy pill — you've probably read enough horror stories online to make you nervous. The reality from clinical trials is more measured. Most people experience some side effects, particularly in the first few weeks. Most of those side effects are manageable and temporary. A small number are serious enough to require medical attention.

This guide breaks down the data from the STEP trials and real-world use so you know what's normal, what's not, and when to pick up the phone.

The Common Side Effects (and How Common They Actually Are)

The STEP 1 trial enrolled over 1,900 adults taking semaglutide 2.4 mg weekly for 68 weeks. The side effect data from that trial, combined with pooled results from STEP 1 through STEP 3, gives us solid percentages.

Nausea is the headliner. In the STEP 1 trial, 44.2% of participants on semaglutide reported nausea versus 17.4% on placebo. That's a real number, but context matters: the vast majority rated their nausea as mild to moderate, and it peaked during the dose escalation phase before fading.

Diarrhea showed up in 31.5% of semaglutide patients (versus 16.2% on placebo). Vomiting in 24.8% (versus 6.4%). Constipation in 24.2% (versus 11.1%). These numbers look high on paper, but 99.5% of all gastrointestinal adverse events in the pooled STEP 1-3 data were classified as non-serious, and 98.1% were mild to moderate.

Other commonly reported side effects include headache, fatigue, dizziness, bloating, and acid reflux. These tend to be less frequent and less disruptive than the core GI symptoms.

Only 4.3% of participants in the semaglutide arms of STEP 1-3 stopped treatment because of gastrointestinal side effects. That number is worth sitting with. Nearly 96% of people who experienced GI issues stuck with the medication.

The Higher-Dose Picture: Wegovy HD (7.2 mg)

The FDA approved Wegovy HD at 7.2 mg in March 2026, based on the STEP UP trial. At this higher dose, gastrointestinal adverse events were reported in 70.8% of participants (versus 61.2% at 2.4 mg and 42.8% on placebo). The side effects remained mostly mild to moderate, and only 3.3% discontinued due to adverse effects.

One notable new finding at the higher dose: dysesthesia — an altered skin sensation described as tingling, burning, or unusual sensitivity — occurred in 22.9% of patients on the 7.2 mg dose versus 6.0% at 2.4 mg. These symptoms generally resolved on their own or with a dose reduction. If you and your provider are considering moving beyond 2.4 mg, this is something to discuss. You can read more about how semaglutide compares to tirzepatide at higher doses.

When Side Effects Start — and When They Fade

Most gastrointestinal side effects follow a predictable timeline. They show up during dose escalation (when your dose increases every four weeks) and taper off once your body adjusts to a stable maintenance dose.

Here's the general pattern:

Weeks 1-4 (0.25 mg): This is the lowest dose, and many people feel little to nothing. Some notice mild nausea or a reduced appetite. Others feel fine.

Weeks 5-12 (0.5 mg to 1 mg): This is where nausea tends to peak for most people. Your body is adjusting to meaningful GLP-1 receptor activation. The nausea is usually worst in the first two to three days after each injection and fades toward the end of the week.

Weeks 13-16 (1.7 mg): Another bump as you titrate up. Some people who sailed through earlier doses notice more GI symptoms here. Constipation often becomes more of a factor at this stage than nausea.

Week 17+ (2.4 mg maintenance): By the time you reach maintenance, most people have adapted. Studies show that the frequency and intensity of GI side effects drop significantly after the dose escalation period ends. Most nausea resolves within 4 to 8 weeks of reaching a stable dose.

The dose titration calculator can help you map out your personal timeline and know what to expect at each stage.

Serious but Rare Side Effects

These are less common, but they're the ones that matter most to discuss with your provider.

Pancreatitis

Acute pancreatitis has been reported in patients taking semaglutide and other GLP-1 medications. The absolute risk in clinical trials was low — under 0.5% — but the condition is serious. Symptoms include severe, persistent abdominal pain that radiates to your back, often accompanied by vomiting. This is not the same as the general stomach discomfort that comes with dose titration. If you experience sudden, intense abdominal pain, stop the medication and get medical help immediately.

Patients with a history of pancreatitis should talk with their provider before starting semaglutide, as the risk may be higher.

Thyroid C-Cell Tumors

Semaglutide carries a boxed warning — the FDA's most serious type — about thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). This warning exists because semaglutide caused thyroid tumors in rodent studies at clinically relevant exposures.

In humans, the data is more reassuring. Across multiple large studies, thyroid cancer cases were rare and occurred at rates below 1% in both treatment and placebo groups. The causal link hasn't been established in people. Still, semaglutide is contraindicated if you have a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Most providers will screen your thyroid function before prescribing.

Gallbladder Problems

Gallbladder events — primarily gallstones (cholelithiasis) — occurred in about 2.6% of semaglutide patients versus 1.2% on placebo in the STEP trials. Rapid weight loss itself is a known risk factor for gallstones, so it's hard to separate the drug effect from the weight loss effect. Symptoms to watch for include sharp pain in the upper right abdomen, especially after eating fatty foods, sometimes with nausea or fever.

Kidney Injury

Dehydration from persistent vomiting or diarrhea can stress the kidneys. This isn't a direct effect of semaglutide, but it's a downstream risk if GI side effects become severe and fluid intake doesn't keep up. Staying hydrated matters, particularly during dose escalation.

Hypoglycemia

Semaglutide alone rarely causes dangerously low blood sugar. The risk increases when it's combined with insulin or sulfonylureas for diabetes management. If you're on multiple diabetes medications, your provider should adjust doses accordingly. The drug interaction checker can flag potential concerns.

Practical Tips for Managing Nausea

Nausea is the side effect that derails people most often — not because it's dangerous, but because it's unpleasant enough to make you question whether this is worth it. Here are strategies that consistently help.

Eat smaller, more frequent meals. Your stomach is emptying slower on semaglutide. A standard three-meal-a-day pattern can overwhelm it. Shifting to five or six smaller meals, keeping each around 250-300 calories, gives your digestive system less to deal with at once. Many patients report a significant drop in nausea within days of making this switch.

Prioritize protein and limit fat. High-fat and greasy foods are the single biggest nausea trigger for people on semaglutide. Lean proteins, whole grains, and cooked vegetables tend to be much better tolerated. This isn't about a strict diet. It's about avoiding the foods that will make you feel terrible.

Try ginger. This isn't folk wisdom — ginger has genuine antiemetic properties. Ginger tea, ginger capsules (about 1 gram daily), or even raw ginger in a smoothie can take the edge off. It won't eliminate nausea entirely, but a 2023 trial found it reduced self-reported nausea scores by about 27%.

Separate food and water. Drinking large amounts of liquid with meals can worsen nausea when gastric emptying is already slowed. Sip water throughout the day, but try to keep significant fluid intake to 30-60 minutes before or after eating rather than during.

Eat slowly and stop when you're done. Semaglutide changes your satiety signals. The portion size that felt normal before may be too much now. Eating slowly gives those signals time to register. If you feel full, stop — even if there's food on the plate.

Time your injection strategically. Some patients find that injecting before bed helps them sleep through the worst of the nausea. Others prefer a morning injection so they can manage symptoms while awake. There's no medically correct answer here. Experiment to find what works.

If nausea persists despite these changes, talk to your provider. They may slow the titration schedule (staying at a lower dose for an extra four weeks) or, in some cases, prescribe an antiemetic like ondansetron for temporary relief.

When to Call Your Doctor vs. When to Ride It Out

Not every side effect requires a phone call. Here's a practical framework.

Ride it out (but monitor): Mild nausea that comes and goes in the first few days after a dose increase. Loose stools or mild constipation that respond to dietary changes. Slight fatigue or headache in the first couple of weeks. These are your body adjusting to the medication, and they typically resolve on their own.

Contact your provider within a day or two: Nausea or vomiting that persists for more than 72 hours without improvement. Constipation lasting more than a week that doesn't respond to increased fiber and water. Any new symptoms that start well after you've stabilized on a dose (not during escalation). Persistent dizziness or fatigue that affects daily functioning.

Call your provider or seek urgent care immediately: Severe abdominal pain that doesn't let up, especially if it radiates to your back (possible pancreatitis). Vomiting that prevents you from keeping down fluids for more than 24 hours (dehydration risk). Signs of an allergic reaction — swelling of the face, lips, tongue, or throat, difficulty breathing, severe rash. A noticeable lump or swelling in your neck, or difficulty swallowing (thyroid concern). Yellowing of the skin or eyes (jaundice).

If you're ever unsure, call. Your provider would rather hear from you about something minor than miss something that needed attention.

Side Effects Compared: Semaglutide vs. Tirzepatide

Both semaglutide and tirzepatide share similar GI side effect profiles since they both activate GLP-1 receptors. In the SURMOUNT-5 head-to-head trial, tirzepatide showed comparable rates of nausea, diarrhea, and constipation. The overall tolerability was similar between the two drugs, though tirzepatide's dual GIP/GLP-1 mechanism may affect individual patients differently.

If you're comparing options, the GLP-1 overview guide covers how all the current medications stack up. For help finding a provider who can walk you through your specific risk factors, the provider quiz matches you with licensed clinics in your area.

How to Minimize Side Effects Before You Start

The single most important thing you can do is follow the titration schedule. Every time a dose is rushed or skipped, the risk of severe side effects goes up. The reason semaglutide starts at 0.25 mg and takes four to five months to reach 2.4 mg is specifically to give your GI system time to adapt.

Beyond that: establish good eating habits before your first injection. If you're currently eating large meals high in fried food, making that shift during dose escalation will be much harder than making it beforehand. A provider who takes the time to set expectations — including what to eat, when to expect symptoms, and when to call — makes a meaningful difference in how tolerable the experience is.

If you're looking for a provider who will actually walk you through this process rather than just hand you a prescription, start with the matching quiz. It connects you with clinics that emphasize patient education and proper titration protocols. You can also use the weight loss projection tool to get a realistic sense of expected results over time.

Semaglutide Side Effects FAQ

How long does semaglutide nausea last?

For most people, nausea peaks during the first four to eight weeks of dose escalation and improves significantly once a stable maintenance dose is reached. In the STEP trials, the majority of nausea episodes were transient and occurred shortly after dose increases. Some patients experience minimal nausea from the start, while others deal with it for the full titration period. Eating smaller meals, avoiding high-fat foods, and working with your provider on titration pacing can shorten the duration.

What are the most common side effects of Ozempic and Wegovy?

The most common side effects across the STEP clinical trials were nausea (44%), diarrhea (32%), vomiting (25%), constipation (24%), headache, fatigue, and bloating. These are all related to how semaglutide slows gastric emptying and alters appetite signaling. The vast majority are mild to moderate and resolve during or shortly after dose escalation. Only about 4% of trial participants stopped treatment due to GI side effects.

Can semaglutide cause hair loss?

Hair loss (telogen effluvium) has been reported by some patients taking semaglutide. This is likely related to rapid weight loss rather than the drug itself — significant calorie reduction and rapid weight change can push hair follicles into a resting phase. It's typically temporary and resolves as weight stabilizes. In the STEP UP trial testing the higher 7.2 mg dose, hair loss was listed among the more commonly reported side effects. Adequate protein intake may help reduce this risk.

Does semaglutide cause pancreatitis?

Acute pancreatitis is a rare but documented risk with semaglutide and other GLP-1 medications. The rate in clinical trials was below 0.5%. Symptoms include severe, sudden abdominal pain radiating to the back, persistent vomiting, and fever. Anyone with a history of pancreatitis should discuss this risk with their provider before starting treatment. If you develop these symptoms, stop the medication and seek medical care immediately.

Are semaglutide side effects worse at higher doses?

Generally, yes. The STEP UP trial confirmed that gastrointestinal side effects were more frequent at the 7.2 mg dose (70.8%) compared to 2.4 mg (61.2%). Dysesthesia (altered skin sensation) was notably higher at 7.2 mg as well. This is exactly why titration exists — starting low and increasing gradually gives your body time to adjust at each level. The titration calculator can help you visualize the timeline.

Should I take semaglutide with food or on an empty stomach?

Injectable semaglutide (Ozempic, Wegovy injections) can be taken with or without food — there's no requirement either way. Oral semaglutide (the Wegovy pill, Rybelsus) is different: it must be taken on an empty stomach with no more than 4 ounces of plain water, at least 30 minutes before your first food, drink, or other medications of the day. For the injectable, some patients find that injecting before bed helps them sleep through early nausea.

What is the cost of semaglutide and how do I find a provider?

Brand-name Wegovy injection lists at over $1,300 per month, though Novo Nordisk offers cash-pay options starting at $299/month for the injection and around $149/month for the new oral pill. Insurance coverage varies widely. For a breakdown of pricing options, check the cost guide. To find a licensed provider near you, the provider matching quiz takes about two minutes and filters by your specific goals and location.